Development
CME Group Inc.
CME
$271.28
$1.580.59%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 5.25B | 5.04B | 4.93B | 4.83B | 4.75B |
| Total Other Revenue | 316.90M | 302.60M | 292.60M | 274.30M | 255.20M |
| Total Revenue | 5.57B | 5.34B | 5.23B | 5.10B | 5.01B |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 5.57B | 5.34B | 5.23B | 5.10B | 5.01B |
| SG&A Expenses | 1.57B | 1.54B | 1.52B | 1.49B | 1.46B |
| Depreciation & Amortization | 352.60M | 356.90M | 358.60M | 359.40M | 362.60M |
| Other Operating Expenses | 188.20M | 216.80M | 203.60M | 196.80M | 187.20M |
| Total Operating Expenses | 2.11B | 2.11B | 2.08B | 2.05B | 2.01B |
| Operating Income | 3.46B | 3.23B | 3.15B | 3.06B | 3.00B |
| Income Before Tax | 4.15B | 3.97B | 3.88B | 3.73B | 3.49B |
| Income Tax Expenses | 927.40M | 925.40M | 901.70M | 867.10M | 799.30M |
| Earnings from Continuing Operations | 3.23K | 3.05K | 2.98K | 2.86K | 2.69K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.23B | 3.05B | 2.98B | 2.86B | 2.69B |
| EBIT | 3.46B | 3.23B | 3.15B | 3.06B | 3.00B |
| EBITDA | 3.81B | 3.58B | 3.50B | 3.42B | 3.37B |
| EPS Basic | 8.87 | 8.39 | 8.20 | 7.88 | 7.41 |
| Normalized Basic EPS | 7.23 | 6.92 | 6.76 | 6.50 | 6.08 |
| EPS Diluted | 8.87 | 8.38 | 8.19 | 7.88 | 7.40 |
| Normalized Diluted EPS | 7.22 | 6.91 | 6.75 | 6.49 | 6.07 |
| Average Basic Shares Outstanding | 1.44B | 1.44B | 1.44B | 1.44B | 1.43B |
| Average Diluted Shares Outstanding | 1.44B | 1.44B | 1.44B | 1.44B | 1.44B |
| Dividend Per Share | 4.40 | 4.30 | 4.20 | 4.10 | 4.00 |
| Payout Ratio | 100.29% | 104.90% | 106.15% | 109.14% | 97.86% |